相关实验视频

Updated: Jun 5, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

柳昆虫茶多可以通过保护肠道屏障和调节肠道微生物群来改善DSS诱导的实验性结肠炎

Xinyu Feng¹, Yanwen Chen², Lina Luo³

¹Tea Research Institute, Zhejiang University, Hangzhou, China; Department of Food Science, Zhejiang University, Hangzhou, China.

|December 4, 2024

概括

柳宝昆虫茶多 (LITP) 显示出对结肠炎的治疗潜力. 在小鼠中,LITP治疗改善了肠道屏障功能和调节了肠道微生物群,减少了炎症和结肠炎症状.

科学领域:

药理学药理学是指药理学的学科.
胃肠病学胃肠病学
微生物学微生物学

背景情况:

柳宝昆虫茶 (LIT) 是一种传统产品.
聚是具有潜在健康益处的生物活性化合物.
实验性结肠炎是炎症性肠病的一个模型.

研究的目的:

调查Liubao昆虫茶多 (LITP) 对小鼠硫酸诱导的大肠炎的治疗作用.
确定LITP中的关键化合物及其作用机制.

主要方法:

提取和识别LIT聚醇 (LITP).
试验性小鼠大肠炎的诱导使用硫酸德克斯.
评估大肠炎的严重程度,包括体重,腹和直肠出血.
结肠组织的组织病理学检查,以评估炎症和损伤.
对表皮屏障完整性和促炎性细胞因子水平的分析.
16S rRNA基因测序以分析肠道微生物群的组成.

主要成果:

LITP治疗显著缓解了结肠炎症状,并减少了结肠损伤.
LITP增强了上皮细胞屏障的完整性,并降低了促炎细胞因子.
LITP调节了肠道微生物群,增加了有益的细菌 (例如Akkermansia),减少了有害的细菌 (例如Turicibacter).

结论:

在实验性结肠炎中,LITP显示出显著的治疗潜力.
LITP的保护作用归因于其强化肠道屏障和调节肠道微生物群的能力.
LITP代表了一种有前途的天然化合物,用于管理炎症性肠道疾病.

关键词:

大肠炎是一种炎症.我们的肠道微生物群.炎症炎症是一种炎症.昆虫茶是一种昆虫茶.肠道屏障肠道屏障肠道屏障柳宝昆虫茶中的多醇.

更多相关视频

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation

Published on: July 27, 2022

相关概念视频

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Drugs for Treatment of Constipation-Predominant IBS

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...